Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Organon & Co. Director's Dealing 2025

May 7, 2025

31461_dirs_2025-05-07_fe6b0805-cef1-42bc-8033-d5de5aa16605.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2025-05-06

Reporting Person: Weaver Kirke (Gen. Counsel & Corp. Secy.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-06 Common Stock P 8045 $9.205 Acquired 52489 Direct